Orthofix (NSDQ:OFIX) today said it fully launched its Oscar Pro ultrasonic arthroplasty revision system in the U.S. and Europe. The ultrasonic surgical system’s creators designed it to aid in the removal of cement during complex joint revision surgeries. Oscar Pro’s new design includes an enhanced user interface to enable a more efficient surgical experience and new […]
Orthofix
Orthofix beats The Street in Q1 results
Orthofix (NSDQ:OFIX) posted first-quarter results today that beat the consensus forecast on Wall Street. The Lewisville, Texas-based company reported losses of -$5.8 million, or -30¢ per share, on sales of $105.6 million for the three months ended March 31, for a sales growth of 0.73% compared with Q1 2020. Adjusted to exclude one-time items, earnings per […]
Orthofix signs exclusive licensing agreement for Igea’s bone and joint stimulation devices
Orthofix (NSDQ:OFIX) today said it entered an exclusive license agreement to commercialize Igea‘s bone, cartilage and soft tissue stimulation products in the U.S. and Canada. Through the agreement, Orthofix has the rights to pursue FDA approvals and commercialization of Italy-based Igea’s platform of orthopedic products. Orthofix will market the products, which will expand its bone […]
The 10 largest orthopedic device companies in the world
Pent-up demand could make orthopedic devices a hot space in 2021. The COVID-19 pandemic was especially brutal for the orthopedic device industry. Many of the largest companies in the space saw double-digit percentage declines in revenue in 2020. Health providers delayed or canceled elective procedures to focus on the pandemic, and patients stayed away in […]
Orthofix wins FDA clearance for 3D printed TLIF spacer system
Orthofix (NSDQ:OFIX) today said it received FDA 510(k) clearance for its Forza Ti TLIF spacer system. The Forza Ti spacer is designed to optimize transforaminal lumbar interbody fusion (TLIF) procedures, according to the company. It has a titanium 3D-printed interbody with porosity and surface that allows bones to grow into and through the spacer. Interbody […]
FDA clears Orthofix 3D-printed titanium cervical spacer system
Orthofix Medical (NSDQ:OFIX) announced today that it received FDA 510(k) clearance for its Construx Mini Ti spacer system. Lewisville, Texas–based Orthofix also administered the first patient implant of the 3D-printed Construx Mini Ti system, which is designed to enhance anterior cervical discectomy and fusion (ACDF) procedures, according to a news release. The Construx Mini Ti […]
Orthofix launches Fitbone limb lengthening system
Orthofix (NSDQ:OFIX) today said it launched its Fitbone intramedullary lengthening system in the U.S. and Europe. The system is designed for limb lengthening and deformity correction of the femur and tibia bones. The lengthening nail is a fully implantable system for correcting leg length and deformity discrepancies. “Orthofix is the only orthopedic company that offers a […]
Orthofix soars on Street-beating Q3 results
Orthofix (NSDQ:OFIX) today posted third-quarter results that beat the consensus on Wall Street. The Lewisville, Texas-based company reported profits of $4.7 million, or 24¢ per share, on sales of $111 million for the three months ended Sept. 30, for a sales loss of -2.2% compared with Q3 2019. Adjusted to exclude one-time items, earnings per share […]
Orthofix, Neo Medical partner to develop single-use spine devices
Orthofix (NSDQ:OFIX) and Neo Medical announced today that they are partnering to develop and market outcome-driven procedural solutions. The partnership and investment agreement comprise a collaboration designed to develop a cervical platform and deploy single-use, sterile-packed procedure solutions to increase operating room efficiency, reduce procedural times and costs, improve outcomes and reduce infection rates, according to […]
Orthofix names new global extremities president
Orthofix (NSDQ:OFIX) announced that it appointed Paul Gonsalves as the president of its global extremities business. Gonsalves joins Lewisville, Texas-based Orthofix after previously serving as chief commercial officer at Integra LifeSciences (NSDQ:IART). He also served as senior VP of enterprise sales and corporate marketing at the medtech company. Before his roles at Integra, Gonsalves served as senior VP […]
SEC awards $2.5M to Orthofix whistleblowers
The SEC announced yesterday that it awarded more than $2.5 million to joint whistleblowers who reportedly raised concerns over Orthofix (NSDQ:OFIX). Although the SEC did not name the company related to the whistleblower award in its news release, Reuters reported that an attorney for the whistleblowers confirmed that the money was awarded as a result of […]
